Spanish Red Biotech Pipeline

MSD

Pembrolizumab + Lenvatinibb

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Previously untreated advanced or metastatic nccRCC
Phase: 2Phase II in Spain, 1Phase I